Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Gastroenterol Clin Biol ; 17(10): 758-61, 1993.
Artigo em Francês | MEDLINE | ID: mdl-8288085

RESUMO

We report a case of abdominal paraesophageal bronchogenic cyst in a 19 year-old patient who complained of dysphagia. Based on this exceptional finding, the authors state overview the pathogenic theories and the histologic features which distinguish para-esophageal bronchogenic cysts from duplications. Preoperative diagnosis is difficult, but endoscopic ultrasound seems to be the imaging method of choice.


Assuntos
Cisto Broncogênico/diagnóstico , Doenças do Esôfago/diagnóstico , Adulto , Cisto Broncogênico/congênito , Cisto Broncogênico/diagnóstico por imagem , Cisto Broncogênico/cirurgia , Endoscopia do Sistema Digestório , Doenças do Esôfago/congênito , Doenças do Esôfago/diagnóstico por imagem , Doenças do Esôfago/cirurgia , Humanos , Imageamento por Ressonância Magnética , Masculino , Tomografia Computadorizada por Raios X , Ultrassonografia
2.
Gastroenterol Clin Biol ; 17(8-9): 529-34, 1993.
Artigo em Francês | MEDLINE | ID: mdl-8253308

RESUMO

Follicular gastritis (FG) is characterized by lymphoid follicle hyperplasia in the gastric mucosa. The aim of this prospective study was to determine the prevalence of FG in adults, their relation to Helicobacter pylori infection, and their histological and endoscopic features. Of 445 patients (379 men, 66 women), 36.4 years old (range: 18-86), FG was detected in 63 patients (14.2%). This was highly significantly associated with H. pylori infection: 49/138 infected patients (35.5%) versus 14/307 non infected patients (4.6%) (P < 0.001). None of the histological features of the antral mucosa were correlated with FG. The prevalence of FG in patients less than 20 years old (in 45.4%) and between 20 and 40 years (in 41.3%) was higher than in patients aged from 40 to 60 years (in 33%) and older than 60 years (in 23%) (no significant difference). No one endoscopic feature of the gastric mucosa was predictive of the presence of FG. We conclude that FG is highly correlated with H. pylori infection and represents a local immune response to bacterial antigens. Their occurrence is probably multifactorial and related to age, duration of infection, bacterial strains, host immune status.


Assuntos
Gastrite/epidemiologia , Infecções por Helicobacter/epidemiologia , Helicobacter pylori/isolamento & purificação , Antro Pilórico/microbiologia , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Biópsia , Doença Crônica , Endoscopia Gastrointestinal , Feminino , Gastrite/diagnóstico por imagem , Gastrite/microbiologia , Gastrite/patologia , Infecções por Helicobacter/diagnóstico por imagem , Infecções por Helicobacter/microbiologia , Infecções por Helicobacter/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Prospectivos , Antro Pilórico/patologia , Radiografia
3.
Gastroenterol Clin Biol ; 16(12): 984-7, 1992.
Artigo em Francês | MEDLINE | ID: mdl-1493900

RESUMO

A French national enquiry examined 4,530 cases of cancer of the exocrine pancreas treated from 1982 to 1989. Ultrasonography was performed in 98% of cases. Other radiological or biological investigations varied from one department to another (P < 0.001). Of 769 patients seen in Gastroenterology departments, 47% (range: 0 to 72%) were operated on. Of 3,761 patients undergoing operation, surgical techniques differed significantly from one department to another (P < 0.001). Resections were performed in 21% (range: 2 to 45%) of cases. Causes of unresectability, choice of biliary bypass, indications for gastrojejunostomy, and use of splanchnicectomy varied from one surgical department to another (P < 0.01). Wide variance in therapeutic policies may be explained by differences in local indications or surgical expertise, giving support to the need for a consensus conference to discern the indications of the available therapeutic alternatives for cancer of the exocrine pancreas.


Assuntos
Neoplasias Pancreáticas/diagnóstico por imagem , Desvio Biliopancreático , Humanos , Neoplasias Pancreáticas/cirurgia , Radiografia , Estudos Retrospectivos , Inquéritos e Questionários , Ultrassonografia
4.
Rev Med Interne ; 13(5): 359-63, 1992.
Artigo em Francês | MEDLINE | ID: mdl-1344831

RESUMO

Omeprazole is the first of a new class of drugs (proton pump blockers) approved in the United States and in Europe for its high efficiency as an inhibitor of gastric acid secretion. Omeprazole is a drug for short term use in patients with acid-peptic disease. A limited prevalence of hepatotoxic effects is reported by some authors (transitory rise in serum aminotransferase level) and it may be prescribed in patients with chronic liver disease although slower metabolism and greater bioavailability are observed. Omeprazole interacts with the cytochrome P-450 system in the liver: inhibition of several liver mono-oxygenases activities (inhibitory effect on diazepam, phenytoin and R-warfarin metabolism with prolonged elimination); induction of P-450 (IA1 and IA2) enzymes that may potentiate the hepatotoxic effect of phenacetin and acetaminophen or increase the tumorigenic effect of chemical carcinogens (polycyclic aromatic hydrocarbons, arylamines, aflatoxin). This latter concern is unfounded as based on a false extrapolation from the results of in vitro studies to those of in vivo situations. However, although omeprazole has proved to be remarkably free of side effects, postmarketing surveillance is recommended for potential interaction with other drugs that are known to be metabolized by the same liver enzymes.


Assuntos
Fígado/efeitos dos fármacos , Omeprazol/farmacologia , Fatores Etários , Disponibilidade Biológica , Doença Crônica , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Interações Medicamentosas , Ácido Gástrico/metabolismo , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Humanos , Fígado/enzimologia , Hepatopatias/sangue , Hepatopatias/tratamento farmacológico , Hepatopatias/metabolismo , Taxa de Depuração Metabólica , Omeprazol/sangue , Omeprazol/química , Omeprazol/uso terapêutico , Vigilância de Produtos Comercializados , Distribuição Tecidual , Transaminases/sangue
5.
Ann Cardiol Angeiol (Paris) ; 39(9): 527-30, 1990 Nov.
Artigo em Francês | MEDLINE | ID: mdl-2291618

RESUMO

The authors report the observation of a paraprosthetic fistula revealed by three episodes of digestive haemorrhage, illustrating the diagnostic and therapeutic difficulties brought about by the erosion of the duodenum by a sub-renal aortic prosthesis. A review of the literature confirms the rarity and the gravity of this pathology, and underlines the per-operative preventive measures.


Assuntos
Doenças da Aorta/complicações , Duodenopatias/complicações , Fístula/complicações , Hematemese/etiologia , Próteses e Implantes/efeitos adversos , Aneurisma Aórtico/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Recidiva , Reoperação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA